This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: The Innovative Contributions of Toshiyuki Tonohiro
Introduction
Toshiyuki Tonohiro, a talented inventor based in Tokyo, Japan, has made significant contributions to the field of medicinal chemistry. Known for his innovative work, Tonohiro has been instrumental in the development of novel compounds with potential therapeutic applications.
Latest Patents
Toshiyuki Tonohiro holds one notable patent for isooxazole derivatives designed for use as cerebro-active drugs and central muscle relaxants. The compound described in his patent includes various structural features, such as the configuration of oxygen atoms and the presence of hydrocarbon rings. These compounds are particularly relevant for treating cerebral circulatory problems and can be utilized as centrally acting muscle relaxants.
Career Highlights
Throughout his career, Tonohiro has demonstrated a remarkable ability to bridge the gap between scientific research and practical applications. His patent showcases his deep understanding of chemistry and biology, highlighting his role in advancing drug development. He has contributed significantly to the pharmaceutical landscape through his innovative ideas and expertise.
Collaborations
At Sankyo Company, Limited, Tonohiro works alongside esteemed colleagues such as Mitsuo Nagano and Junichi Sakai. These collaborations have fostered an environment of creativity and innovation, culminating in the successful development of compounds aimed at addressing critical health issues.
Conclusion
Toshiyuki Tonohiro stands out as an accomplished inventor with a focus on creating innovative solutions for medical challenges. His contributions, particularly in the field of isoxazole derivatives, reflect his commitment to improving healthcare outcomes through scientific innovation. The potential applications of his work continue to inspire future advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
